Overview
Portfolio
More
Pace Ventures
Menlo Park, United States
Better drugs faster using deep learning to design PROTACs and target undruggable proteins.
Portfolio
16+
Employees
N/A
Founded
2021
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
AustriaUnited States
Sources
Pace Ventures
Better drugs faster using deep learning to design PROTACs and target undruggable proteins.
Portfolio
16+
Employees
N/A
Founded
2021
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
AustriaUnited States
Sources
Showing 13 of 13 matched portfolio companies
Aerones provides robotic technology for the maintenance and inspection of wind turbine blades, utilizing patented robotics to enhance operational efficiency. Their services significantly reduce maintenance time and costs while improving safety and precision, addressing the challenges of traditional wind turbine upkeep.
Funding: $50.9M
Rough estimate of the amount of funding raised
Funding: $50.9M
Rough estimate of the amount of funding raised
Bitfount provides a federated AI and data science platform enabling secure collaboration across life sciences and clinical research organizations. The platform allows algorithms to run directly on distributed data sources, such as imaging and EHR systems, without requiring data extraction or sharing. This facilitates faster patient recruitment, site feasibility analysis, and cross-silo AI development while maintaining data privacy and security behind the firewall.
Funding: $7.1M
Rough estimate of the amount of funding raised
Funding: $7.1M
Rough estimate of the amount of funding raised
Cellbyte provides a collaborative AI workspace for Pricing & Market Access teams to streamline intelligence gathering and analysis. The platform integrates global regulatory, HTA, access, and pricing data, extracting insights from complex documents instantly. This capability accelerates opportunity assessment, competitive intelligence, and evidence validation for optimized market access performance.
Funding: $500.0K
Rough estimate of the amount of funding raised
Funding: $500.0K
Rough estimate of the amount of funding raised
ChemFinity engineers advanced separations technologies focused on critical mineral recovery and resource circularity, starting with precious metals. This technology efficiently extracts valuable resources to support a secure domestic supply chain. The company aims to reduce the environmental impact associated with industrial separations and metal mining processes.
Clearly provides a platform for managing and optimizing complex supply chain logistics across global networks. The service integrates real-time tracking and predictive analytics to enhance operational visibility and reduce transit delays. This results in more efficient inventory management and lower landed costs for businesses relying on international freight.
Funding: $8.7M
Rough estimate of the amount of funding raised
Funding: $8.7M
Rough estimate of the amount of funding raised
Dunia Innovations accelerates the discovery of electroactive materials for the chemical industry by utilizing robotics and advanced algorithms, reducing research and development timelines from 20 years to just 2 years. This technology enables the production of cost-effective green chemicals and fuels, addressing the urgent need for material innovation to achieve net-zero emissions.
Funding: $11.6M
Rough estimate of the amount of funding raised
Funding: $11.6M
Rough estimate of the amount of funding raised
ELE Group provides affordable clean energy solutions through the deployment of decentralized renewable energy systems, ensuring access for underserved communities. The company focuses on eliminating energy poverty by integrating solar and wind technologies to deliver reliable power at lower costs.
FabricNano develops cell-free biomanufacturing processes that utilize biocatalysts and natural materials to produce sustainable products. This technology addresses the environmental impact of traditional manufacturing by enabling efficient, eco-friendly production methods.
Funding: $15.5M
Rough estimate of the amount of funding raised
Funding: $15.5M
Rough estimate of the amount of funding raised
Holobiome develops targeted therapies derived from the human microbiome to address diseases affecting the enteric and central nervous systems. By leveraging microbiome science, the company aims to create next-generation probiotics that enhance whole-body health.
Neurable develops brain-computer interfaces (BCIs) that utilize machine learning and signal processing to translate neural activity into actionable commands for everyday devices. This technology enables individuals with mobility impairments to interact with software and hardware hands-free, enhancing their ability to engage with the digital world.
Funding: $30.9M
Rough estimate of the amount of funding raised
Funding: $30.9M
Rough estimate of the amount of funding raised
Photara develops metallization processes that replace silver with copper and aluminum in photovoltaic cells, cutting material costs by up to 20%. Their material science and robotics expertise enables high‑conductivity, low‑cost metal contacts compatible with existing solar manufacturing lines. This approach lowers the overall cost of solar modules and supports large‑scale deployment of renewable energy.
Turnover Labs utilizes an ultra-durable electrolysis system to convert dilute CO2 emissions into high-value chemical products. This waste-to-value technology enables on-site, modular production, avoiding complex global supply chains. The system offers chemical manufacturers a pathway to low-carbon feedstocks at competitive prices while mitigating carbon taxes.
Funding: $1.4M
Rough estimate of the amount of funding raised
Funding: $1.4M
Rough estimate of the amount of funding raised
Virtonomy provides a digital twin solution, v-Patients, that utilizes AI and multi-physics simulations to enable medical device developers to conduct virtual testing and optimization. This approach accelerates product development, reduces costs, and minimizes regulatory burdens by allowing for early safety and performance assessments in a diverse range of anatomical scenarios.
Funding: $3.8M
Rough estimate of the amount of funding raised
Funding: $3.8M
Rough estimate of the amount of funding raised
Showing 3 of 3 unmatched portfolio companies